TERNS PHARMACEUTICALS INC: OPPENHEIMER LOWERS RATING TO PERFORM FROM OUTPERFORM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 27 2026
0mins
Source: moomoo
Company Overview: Tern Pharmaceuticals is a company focused on developing innovative therapeutics in the pharmaceutical sector.
Recent Performance: The company has recently experienced a decline in performance, moving from an outperforming status to a cut in performance ratings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
